The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or inhalation. A nasal COVID-19 vaccine, developed using technology from Washington ...
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...
The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...
Nandita Vijayasimha, Bengaluru Thursday, February 6, 2025, 08:00 Hrs [IST] ...
Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an ...
Emergent BioSolutions (EBS) announced that it is raising awareness of the Ready to Rescue initiative in New Orleans with pro football legend ...
The money will pay for efforts to prevent and treat opioid addiction, or fund services that help people in recovery.
The FDA reveals that phenylephrine, a popular decongestant, is no better than a placebo. Discover what this means for your ...